Tag: Vaccines
Physician’s Briefing Weekly Coronavirus Roundup
FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
Exactly who qualifies as high risk because of health or work reasons is not yet clear
HPV Vaccine Will Have Modest Impact on Oropharynx Cancer Incidence by 2045
However, reductions in oropharynx cancer incidence should be seen among young and middle-aged adults
CDC Expert Panel to Weigh In on Vaccine Boosters
Panel will deliberate which high-risk groups should get a booster shot
U.S. to Buy 500 Million More COVID-19 Vaccine Doses for Global Donation
Some 160 million shots from the United States have been given to more than 100 countries
Moderna Vaccine Top for Protection Against COVID-19 Hospitalization
Vaccine effectiveness higher for Moderna than Pfizer-BioNTech vaccine; both mRNA vaccines have higher VE than Janssen
Booster Dose of J&J COVID-19 Vaccine May Increase Immunity
New research indicates two doses of the vaccine boosts immunity from 74 to 94 percent
Review of Booster Shots for Moderna, J&J Vaccines Just Weeks Away: Fauci
Fauci says data on booster shots for those vaccines are only a few weeks away from a review by the FDA
Lower Dose of Pfizer COVID-19 Vaccine Works Well in Young Children
Finding is crucial step toward the Pfizer two-shot regimen becoming available for younger children as early as Halloween
FDA Panel Says Yes to Pfizer Booster Shots for People 65+
Same independent panel of experts said no to booster shots for Americans younger than 65 years
